APO Research
Talk to an analyst

APO RESEARCH · REPORT

Respiratory Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Respiratory Disease Vaccine Industry Growth and Trends Forecast to 2032

28 December 2025104 pages

Choose your research edition.

Industry ResearchRespiratory Disease Vaccine Industry Research Report 2026121 pages · $2,950 USDIndustry Growth & TrendsGlobal Respiratory Disease Vaccine Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Respiratory Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Respiratory Disease Vaccine Market Outlook and Growth Opportunities 2026197 pages · $4,250 USDMarket Analysis & ForecastGlobal Respiratory Disease Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Respiratory Disease Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Respiratory Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Respiratory Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Respiratory Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Respiratory Disease Vaccine include Sanofi SA, Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., SINOVAC, Serum Institute of India Pvt. Ltd., Novavax, GSK plc. and Emergent BioSolutions Inc., among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Respiratory Disease Vaccine market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Respiratory Disease Vaccine market size, estimates, and forecasts are presented in terms of sales volume (K Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Respiratory Disease Vaccine market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Respiratory Disease Vaccine.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Respiratory Disease Vaccine market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Respiratory Disease Vaccine Market by Company

Sanofi SA

Johnson & Johnson Services, Inc.

Merck & Co., Inc.

Pfizer Inc.

SINOVAC

Serum Institute of India Pvt. Ltd.

Novavax

GSK plc.

Emergent BioSolutions Inc.

AstraZeneca

Respiratory Disease Vaccine Segment by Type

Live Attenuated

Inactivated

Others

Respiratory Disease Vaccine Segment by Application

Flu

Pneumonia

Others

Respiratory Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Respiratory Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Respiratory Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Respiratory Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Respiratory Disease Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Respiratory Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Live Attenuated Table 2. Major Company of Inactivated Table 3. Major Company of Others Table 4. Global Respiratory Disease Vaccine Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 6. Global Respiratory Disease Vaccine Sales Market Share in Volume by Type (2021-2026) Table 7. Global Respiratory Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 8. Global Respiratory Disease Vaccine Sales Market Share in Value by Type (2021-2026) Table 9. Global Respiratory Disease Vaccine Price by Type (2021-2026) & (US$/Unit) Table 10. Global Respiratory Disease Vaccine Sales by Type (2027-2032) & (K Units) Table 11. Global Respiratory Disease Vaccine Sales Market Share in Volume by Type (2027-2032) Table 12. Global Respiratory Disease Vaccine Sales by Type (2027-2032) & (US$ Million) Table 13. Global Respiratory Disease Vaccine Sales Market Share in Value by Type (2027-2032) Table 14. Global Respiratory Disease Vaccine Price by Type (2027-2032) & (US$/Unit) Table 15. North America Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 16. North America Respiratory Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 17. Europe Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 18. Europe Respiratory Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 19. Asia-Pacific Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 20. Asia-Pacific Respiratory Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 21. Latin America Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 22. Latin America Respiratory Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 23. Middle East and Africa Respiratory Disease Vaccine Sales by Type (2021-2026) & (K Units) Table 24. Middle East and Africa Respiratory Disease Vaccine Sales by Type (2021-2026) & (US$ Million) Table 25. Respiratory Disease Vaccine Industry Trends Table 26. Respiratory Disease Vaccine Industry Drivers Table 27. Respiratory Disease Vaccine Industry Opportunities and Challenges Table 28. Respiratory Disease Vaccine Industry Restraints Table 29. Global Respiratory Disease Vaccine Sales Revenue by Company (US$ Million) & (2021-2026) Table 30. Global Respiratory Disease Vaccine Revenue Market Share by Company (2021-2026) Table 31. Global Respiratory Disease Vaccine Sales by Company (2021-2026) & (K Units) Table 32. Global Respiratory Disease Vaccine Sales Share by Company (2021-2026) Table 33. Global Respiratory Disease Vaccine Market Price by Company (2021-2026) & (US$/Unit) Table 34. Global Respiratory Disease Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026 Table 35. Global Respiratory Disease Vaccine Major Company Production Sites and Headquarters Table 36. Global Respiratory Disease Vaccine Company, Product Type & Application Table 37. Global Respiratory Disease Vaccine Company Establishment Date Table 38. Global Company Market Concentration Ratio (CR5 and HHI) Table 39. Global Respiratory Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 40. Global Respiratory Disease Vaccine Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 41. Global Respiratory Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 42. Global Respiratory Disease Vaccine Sales Market Share in Volume by Region (2021-2026) Table 43. Global Respiratory Disease Vaccine Sales by Region (2021-2026) & (US$ Million) Table 44. Global Respiratory Disease Vaccine Sales Market Share in Value by Region (2021-2026) Table 45. Global Respiratory Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Global Respiratory Disease Vaccine Sales by Region (2027-2032) & (K Units) Table 47. Global Respiratory Disease Vaccine Sales Market Share in Volume by Region (2027-2032) Table 48. Global Respiratory Disease Vaccine Sales by Region (2027-2032) & (US$ Million) Table 49. Global Respiratory Disease Vaccine Sales Market Share in Value by Region (2027-2032) Table 50. Global Respiratory Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2027-2032) Table 51. Global Respiratory Disease Vaccine Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 52. Global Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 53. Global Respiratory Disease Vaccine Sales Market Share in Volume by Application (2021-2026) Table 54. Global Respiratory Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 55. Global Respiratory Disease Vaccine Sales Market Share in Value by Application (2021-2026) Table 56. Global Respiratory Disease Vaccine Price by Application (2021-2026) & (US$/Unit) Table 57. Global Respiratory Disease Vaccine Sales by Application (2027-2032) & (K Units) Table 58. Global Respiratory Disease Vaccine Sales Market Share in Volume by Application (2027-2032) Table 59. Global Respiratory Disease Vaccine Sales by Application (2027-2032) & (US$ Million) Table 60. Global Respiratory Disease Vaccine Sales Market Share in Value by Application (2027-2032) Table 61. Global Respiratory Disease Vaccine Price by Application (2027-2032) & (US$/Unit) Table 62. North America Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 63. North America Respiratory Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 64. Europe Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 65. Europe Respiratory Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 66. Asia-Pacific Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 67. Asia-Pacific Respiratory Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 68. Latin America Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 69. Latin America Respiratory Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 70. Middle East and Africa Respiratory Disease Vaccine Sales by Application (2021-2026) & (K Units) Table 71. Middle East and Africa Respiratory Disease Vaccine Sales by Application (2021-2026) & (US$ Million) Table 72. Sanofi SA Company Information Table 73. Sanofi SA Business Overview Table 74. Sanofi SA Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Sanofi SA Respiratory Disease Vaccine Product Portfolio Table 76. Sanofi SA Recent Development Table 77. Johnson & Johnson Services, Inc. Company Information Table 78. Johnson & Johnson Services, Inc. Business Overview Table 79. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product Portfolio Table 81. Johnson & Johnson Services, Inc. Recent Development Table 82. Merck & Co., Inc. Company Information Table 83. Merck & Co., Inc. Business Overview Table 84. Merck & Co., Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Merck & Co., Inc. Respiratory Disease Vaccine Product Portfolio Table 86. Merck & Co., Inc. Recent Development Table 87. Pfizer Inc. Company Information Table 88. Pfizer Inc. Business Overview Table 89. Pfizer Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Pfizer Inc. Respiratory Disease Vaccine Product Portfolio Table 91. Pfizer Inc. Recent Development Table 92. SINOVAC Company Information Table 93. SINOVAC Business Overview Table 94. SINOVAC Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. SINOVAC Respiratory Disease Vaccine Product Portfolio Table 96. SINOVAC Recent Development Table 97. Serum Institute of India Pvt. Ltd. Company Information Table 98. Serum Institute of India Pvt. Ltd. Business Overview Table 99. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product Portfolio Table 101. Serum Institute of India Pvt. Ltd. Recent Development Table 102. Novavax Company Information Table 103. Novavax Business Overview Table 104. Novavax Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Novavax Respiratory Disease Vaccine Product Portfolio Table 106. Novavax Recent Development Table 107. GSK plc. Company Information Table 108. GSK plc. Business Overview Table 109. GSK plc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. GSK plc. Respiratory Disease Vaccine Product Portfolio Table 111. GSK plc. Recent Development Table 112. Emergent BioSolutions Inc. Company Information Table 113. Emergent BioSolutions Inc. Business Overview Table 114. Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Emergent BioSolutions Inc. Respiratory Disease Vaccine Product Portfolio Table 116. Emergent BioSolutions Inc. Recent Development Table 117. AstraZeneca Company Information Table 118. AstraZeneca Business Overview Table 119. AstraZeneca Respiratory Disease Vaccine Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. AstraZeneca Respiratory Disease Vaccine Product Portfolio Table 121. AstraZeneca Recent Development Table 122. North America Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 123. North America Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 124. North America Respiratory Disease Vaccine Sales Market Share by Country (2021-2026) Table 125. North America Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 126. North America Respiratory Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 127. North America Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 128. North America Respiratory Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 129. North America Respiratory Disease Vaccine Market Share by Country (2021-2026) Table 130. North America Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 131. North America Respiratory Disease Vaccine Market Share Forecast by Country (2027-2032) Table 132. Europe Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 133. Europe Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 134. Europe Respiratory Disease Vaccine Sales Market Share by Country (2021-2026) Table 135. Europe Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 136. Europe Respiratory Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 137. Europe Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 138. Europe Respiratory Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 139. Europe Respiratory Disease Vaccine Market Share by Country (2021-2026) Table 140. Europe Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 141. Europe Respiratory Disease Vaccine Market Share Forecast by Country (2027-2032) Table 142. Asia-Pacific Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 143. Asia-Pacific Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 144. Asia-Pacific Respiratory Disease Vaccine Sales Market Share by Country (2021-2026) Table 145. Asia-Pacific Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 146. Asia-Pacific Respiratory Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 147. Asia-Pacific Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 148. Asia-Pacific Respiratory Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 149. Asia-Pacific Respiratory Disease Vaccine Market Share by Country (2021-2026) Table 150. Asia-Pacific Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 151. Asia-Pacific Respiratory Disease Vaccine Market Share Forecast by Country (2027-2032) Table 152. Latin America Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 153. Latin America Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 154. Latin America Respiratory Disease Vaccine Sales Market Share by Country (2021-2026) Table 155. Latin America Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 156. Latin America Respiratory Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 157. Latin America Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 158. Latin America Respiratory Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 159. Latin America Respiratory Disease Vaccine Market Share by Country (2021-2026) Table 160. Latin America Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 161. Latin America Respiratory Disease Vaccine Market Share Forecast by Country (2027-2032) Table 162. Middle East and Africa Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (K Units): 2021 VS 2025 VS 2032 Table 163. Middle East and Africa Respiratory Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 164. Middle East and Africa Respiratory Disease Vaccine Sales Market Share by Country (2021-2026) Table 165. Middle East and Africa Respiratory Disease Vaccine Sales Forecast by Country (2027-2032) & (K Units) Table 166. Middle East and Africa Respiratory Disease Vaccine Sales Market Share Forecast by Country (2027-2032) Table 167. Middle East and Africa Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 168. Middle East and Africa Respiratory Disease Vaccine Market Size by Country (2021-2026) & (US$ Million) Table 169. Middle East and Africa Respiratory Disease Vaccine Market Share by Country (2021-2026) Table 170. Middle East and Africa Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032) & (US$ Million) Table 171. Middle East and Africa Respiratory Disease Vaccine Market Share Forecast by Country (2027-2032) Table 172. Key Raw Materials Table 173. Raw Materials Key Suppliers Table 174. Respiratory Disease Vaccine Distributors List Table 175. Respiratory Disease Vaccine Customers List Table 176. Research Programs/Design for This Report Table 177. Authors List of This Report Table 178. Secondary Sources Table 179. Primary Sources List of Figures Figure 1. Respiratory Disease Vaccine Image Figure 2. Global Respiratory Disease Vaccine Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Respiratory Disease Vaccine Market Size (2021-2032) & (US$ Million) Figure 4. Global Respiratory Disease Vaccine Sales (2021-2032) & (K Units) Figure 5. Live Attenuated Image Figure 6. Global Live Attenuated Sales YoY Growth (2021-2032) & (K Units) Figure 7. Inactivated Image Figure 8. Global Inactivated Sales YoY Growth (2021-2032) & (K Units) Figure 9. Others Image Figure 10. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 11. Global Respiratory Disease Vaccine Market Size Overview by Type (2021-2032) & (US$ Million) Figure 12. Global Respiratory Disease Vaccine Market Share by Type 2025 VS 2032 Figure 13. North America Respiratory Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 14. North America Respiratory Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 15. Europe Respiratory Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 16. Europe Respiratory Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 17. Asia-Pacific Respiratory Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 18. Asia-Pacific Respiratory Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 19. Latin America Respiratory Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 20. Latin America Respiratory Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 21. Middle East and Africa Respiratory Disease Vaccine Sales Market Share in Volume by Type in 2025 Figure 22. Middle East and Africa Respiratory Disease Vaccine Sales Market Share in Value by Type in 2025 Figure 23. Global Top 5 and 10 Respiratory Disease Vaccine Players Market Share by Revenue in 2025 Figure 24. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 25. Flu Image Figure 26. Global Flu Sales YoY Growth (2021-2032) & (K Units) Figure 27. Pneumonia Image Figure 28. Global Pneumonia Sales YoY Growth (2021-2032) & (K Units) Figure 29. Others Image Figure 30. Global Others Sales YoY Growth (2021-2032) & (K Units) Figure 31. Global Respiratory Disease Vaccine Market Size Overview by Application (2021-2032) & (US$ Million) Figure 32. Global Respiratory Disease Vaccine Market Share by Application 2025 VS 2032 Figure 33. North America Respiratory Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 34. North America Respiratory Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 35. Europe Respiratory Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 36. Europe Respiratory Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 37. Asia-Pacific Respiratory Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 38. Asia-Pacific Respiratory Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 39. Latin America Respiratory Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 40. Latin America Respiratory Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 41. Middle East and Africa Respiratory Disease Vaccine Sales Market Share in Volume by Application in 2025 Figure 42. Middle East and Africa Respiratory Disease Vaccine Sales Market Share in Value by Application in 2025 Figure 43. North America Respiratory Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 44. North America Respiratory Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 45. North America Respiratory Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. North America Respiratory Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Respiratory Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 48. Europe Respiratory Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Respiratory Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 50. Europe Respiratory Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 51. Asia-Pacific Respiratory Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 52. Asia-Pacific Respiratory Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Respiratory Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 54. Asia-Pacific Respiratory Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 55. Latin America Respiratory Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 56. Latin America Respiratory Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Respiratory Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Latin America Respiratory Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 59. Middle East and Africa Respiratory Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Figure 60. Middle East and Africa Respiratory Disease Vaccine Sales Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Respiratory Disease Vaccine Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 62. Middle East and Africa Respiratory Disease Vaccine Market Share by Country: 2021 VS 2025 VS 2032 Figure 63. Respiratory Disease Vaccine Value Chain Figure 64. Key Raw Materials Price Figure 65. Manufacturing Cost Structure Figure 66. Respiratory Disease Vaccine Production Mode & Process Figure 67. Direct Comparison with Distribution Share Figure 68. Distributors Profiles Figure 69. Years Considered Figure 70. Research Process Figure 71. Key Executives Interviewed

Scope & coverage.

Types
  • Live Attenuated
  • Inactivated
  • Others
Applications
  • Flu
  • Pneumonia
  • Others
Companies covered
  • Sanofi SA
  • Johnson & Johnson Services, Inc.
  • Merck & Co., Inc.
  • Pfizer Inc.
  • SINOVAC
  • Serum Institute of India Pvt. Ltd.
  • Novavax
  • GSK plc.
  • Emergent BioSolutions Inc.
  • AstraZeneca

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Respiratory Disease Vaccine Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Respiratory Disease Vaccine Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Respiratory Disease Vaccine Market by Type
  6. 1.3.1 Live Attenuated
  7. 1.3.2 Inactivated
  8. 1.3.3 Others
  9. 1.4 Global Respiratory Disease Vaccine Market Size by Type
  10. 1.4.1 Global Respiratory Disease Vaccine Market Size Overview by Type (2021-2032)
  11. 1.4.2 Global Respiratory Disease Vaccine Historic Market Size Review by Type (2021-2026)
  12. 1.4.3 Global Respiratory Disease Vaccine Forecasted Market Size by Type (2027-2032)
  13. 1.5 Key Regions Market Size by Type
  14. 1.5.1 North America Respiratory Disease Vaccine Sales Breakdown by Type (2021-2026)
  15. 1.5.2 Europe Respiratory Disease Vaccine Sales Breakdown by Type (2021-2026)
  16. 1.5.3 Asia-Pacific Respiratory Disease Vaccine Sales Breakdown by Type (2021-2026)
  17. 1.5.4 South America Respiratory Disease Vaccine Sales Breakdown by Type (2021-2026)
  18. 1.5.5 Middle East and Africa Respiratory Disease Vaccine Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Respiratory Disease Vaccine Industry Trends
  2. 2.2 Respiratory Disease Vaccine Industry Drivers
  3. 2.3 Respiratory Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Respiratory Disease Vaccine Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Respiratory Disease Vaccine Revenue (2021-2026)
  2. 3.2 Global Top Players by Respiratory Disease Vaccine Sales (2021-2026)
  3. 3.3 Global Top Players by Respiratory Disease Vaccine Price (2021-2026)
  4. 3.4 Global Respiratory Disease Vaccine Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Respiratory Disease Vaccine Major Company Production Sites & Headquarters
  6. 3.6 Global Respiratory Disease Vaccine Company, Product Type & Application
  7. 3.7 Global Respiratory Disease Vaccine Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Respiratory Disease Vaccine Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Respiratory Disease Vaccine Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Respiratory Disease Vaccine Tier 1, Tier 2, and Tier 3
4 Respiratory Disease Vaccine Regional Status and Outlook
  1. 4.1 Global Respiratory Disease Vaccine Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Respiratory Disease Vaccine Historic Market Size by Region
  3. 4.2.1 Global Respiratory Disease Vaccine Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Respiratory Disease Vaccine Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Respiratory Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Respiratory Disease Vaccine Forecasted Market Size by Region
  7. 4.3.1 Global Respiratory Disease Vaccine Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Respiratory Disease Vaccine Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Respiratory Disease Vaccine Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Respiratory Disease Vaccine by Application
  1. 5.1 Respiratory Disease Vaccine Market by Application
  2. 5.1.1 Flu
  3. 5.1.2 Pneumonia
  4. 5.1.3 Others
  5. 5.2 Global Respiratory Disease Vaccine Market Size by Application
  6. 5.2.1 Global Respiratory Disease Vaccine Market Size Overview by Application (2021-2032)
  7. 5.2.2 Global Respiratory Disease Vaccine Historic Market Size Review by Application (2021-2026)
  8. 5.2.3 Global Respiratory Disease Vaccine Forecasted Market Size by Application (2027-2032)
  9. 5.3 Key Regions Market Size by Application
  10. 5.3.1 North America Respiratory Disease Vaccine Sales Breakdown by Application (2021-2026)
  11. 5.3.2 Europe Respiratory Disease Vaccine Sales Breakdown by Application (2021-2026)
  12. 5.3.3 Asia-Pacific Respiratory Disease Vaccine Sales Breakdown by Application (2021-2026)
  13. 5.3.4 South America Respiratory Disease Vaccine Sales Breakdown by Application (2021-2026)
  14. 5.3.5 Middle East and Africa Respiratory Disease Vaccine Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Sanofi SA
  2. 6.1.1 Sanofi SA Company Information
  3. 6.1.2 Sanofi SA Business Overview
  4. 6.1.3 Sanofi SA Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Sanofi SA Respiratory Disease Vaccine Product Portfolio
  6. 6.1.5 Sanofi SA Recent Developments
  7. 6.2 Johnson & Johnson Services, Inc.
  8. 6.2.1 Johnson & Johnson Services, Inc. Company Information
  9. 6.2.2 Johnson & Johnson Services, Inc. Business Overview
  10. 6.2.3 Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Johnson & Johnson Services, Inc. Respiratory Disease Vaccine Product Portfolio
  12. 6.2.5 Johnson & Johnson Services, Inc. Recent Developments
  13. 6.3 Merck & Co., Inc.
  14. 6.3.1 Merck & Co., Inc. Company Information
  15. 6.3.2 Merck & Co., Inc. Business Overview
  16. 6.3.3 Merck & Co., Inc. Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Merck & Co., Inc. Respiratory Disease Vaccine Product Portfolio
  18. 6.3.5 Merck & Co., Inc. Recent Developments
  19. 6.4 Pfizer Inc.
  20. 6.4.1 Pfizer Inc. Company Information
  21. 6.4.2 Pfizer Inc. Business Overview
  22. 6.4.3 Pfizer Inc. Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 Pfizer Inc. Respiratory Disease Vaccine Product Portfolio
  24. 6.4.5 Pfizer Inc. Recent Developments
  25. 6.5 SINOVAC
  26. 6.5.1 SINOVAC Company Information
  27. 6.5.2 SINOVAC Business Overview
  28. 6.5.3 SINOVAC Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 SINOVAC Respiratory Disease Vaccine Product Portfolio
  30. 6.5.5 SINOVAC Recent Developments
  31. 6.6 Serum Institute of India Pvt. Ltd.
  32. 6.6.1 Serum Institute of India Pvt. Ltd. Company Information
  33. 6.6.2 Serum Institute of India Pvt. Ltd. Business Overview
  34. 6.6.3 Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Serum Institute of India Pvt. Ltd. Respiratory Disease Vaccine Product Portfolio
  36. 6.6.5 Serum Institute of India Pvt. Ltd. Recent Developments
  37. 6.7 Novavax
  38. 6.7.1 Novavax Company Information
  39. 6.7.2 Novavax Business Overview
  40. 6.7.3 Novavax Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 Novavax Respiratory Disease Vaccine Product Portfolio
  42. 6.7.5 Novavax Recent Developments
  43. 6.8 GSK plc.
  44. 6.8.1 GSK plc. Company Information
  45. 6.8.2 GSK plc. Business Overview
  46. 6.8.3 GSK plc. Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 GSK plc. Respiratory Disease Vaccine Product Portfolio
  48. 6.8.5 GSK plc. Recent Developments
  49. 6.9 Emergent BioSolutions Inc.
  50. 6.9.1 Emergent BioSolutions Inc. Company Information
  51. 6.9.2 Emergent BioSolutions Inc. Business Overview
  52. 6.9.3 Emergent BioSolutions Inc. Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Emergent BioSolutions Inc. Respiratory Disease Vaccine Product Portfolio
  54. 6.9.5 Emergent BioSolutions Inc. Recent Developments
  55. 6.10 AstraZeneca
  56. 6.10.1 AstraZeneca Company Information
  57. 6.10.2 AstraZeneca Business Overview
  58. 6.10.3 AstraZeneca Respiratory Disease Vaccine Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 AstraZeneca Respiratory Disease Vaccine Product Portfolio
  60. 6.10.5 AstraZeneca Recent Developments
7 North America by Country
  1. 7.1 North America Respiratory Disease Vaccine Sales by Country
  2. 7.1.1 North America Respiratory Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Respiratory Disease Vaccine Sales by Country (2021-2026)
  4. 7.1.3 North America Respiratory Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 7.2 North America Respiratory Disease Vaccine Market Size by Country
  6. 7.2.1 North America Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Respiratory Disease Vaccine Market Size by Country (2021-2026)
  8. 7.2.3 North America Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Respiratory Disease Vaccine Sales by Country
  2. 8.1.1 Europe Respiratory Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Respiratory Disease Vaccine Sales by Country (2021-2026)
  4. 8.1.3 Europe Respiratory Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Respiratory Disease Vaccine Market Size by Country
  6. 8.2.1 Europe Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Respiratory Disease Vaccine Market Size by Country (2021-2026)
  8. 8.2.3 Europe Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Respiratory Disease Vaccine Sales by Country
  2. 9.1.1 Asia-Pacific Respiratory Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Respiratory Disease Vaccine Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Respiratory Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Respiratory Disease Vaccine Market Size by Country
  6. 9.2.1 Asia-Pacific Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Respiratory Disease Vaccine Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Respiratory Disease Vaccine Sales by Country
  2. 10.1.1 South America Respiratory Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Respiratory Disease Vaccine Sales by Country (2021-2026)
  4. 10.1.3 South America Respiratory Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 10.2 South America Respiratory Disease Vaccine Market Size by Country
  6. 10.2.1 South America Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Respiratory Disease Vaccine Market Size by Country (2021-2026)
  8. 10.2.3 South America Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Respiratory Disease Vaccine Sales by Country
  2. 11.1.1 Middle East and Africa Respiratory Disease Vaccine Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Respiratory Disease Vaccine Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Respiratory Disease Vaccine Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Respiratory Disease Vaccine Market Size by Country
  6. 11.2.1 Middle East and Africa Respiratory Disease Vaccine Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Respiratory Disease Vaccine Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Respiratory Disease Vaccine Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Respiratory Disease Vaccine Value Chain Analysis
  2. 12.1.1 Respiratory Disease Vaccine Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Respiratory Disease Vaccine Production Mode & Process
  7. 12.2 Respiratory Disease Vaccine Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Respiratory Disease Vaccine Distributors
  10. 12.2.3 Respiratory Disease Vaccine Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst